They concluded that serum NfL levels assessed over the initial years after disease onset, may serve as prognostic tool to predict brain atrophy and MRI lesions for up to 10 years in MS patients (Chitnis et al., 2018[18]). The gene discussed is NEFL; the disease is Brain atrophy.